Literature DB >> 16571843

Peptide YY levels are elevated after gastric bypass surgery.

Jean L Chan1, Edward C Mun, Violeta Stoyneva, Christos S Mantzoros, Allison B Goldfine.   

Abstract

OBJECTIVE: Mechanisms that promote effective and sustained weight loss in persons who have undergone Roux-en-Y gastric bypass surgery are incompletely understood but may be mediated, in part, by changes in appetite. Peptide YY (PYY) is a gut-derived hormone with anorectic properties. We sought to determine whether gastric bypass surgery alters PYY levels or response to glucose. RESEARCH METHODS AND PROCEDURES: PYY and ghrelin levels after a 75-gram oral glucose tolerance test were measured in 6 morbidly obese patients 1.5 +/- 0.7 (SE) years after gastric bypass compared with 5 lean and 12 obese controls.
RESULTS: After substantial body weight loss (36.8 +/- 3.6%) induced by gastric bypass, the PYY response to an oral glucose tolerance test was significantly higher than in controls (p = 0.01). PYY increased approximately 10-fold after a 75-gram glucose load to a peak of 303.0 +/- 37.0 pg/mL at 30 minutes (p = 0.03) and remained significantly higher than fasting levels for all subsequent time-points. In contrast, PYY levels in obese and lean controls increased to a peak of approximately 2-fold, which was only borderline significant. Ghrelin levels decreased in a symmetric but opposite fashion to that of PYY. DISCUSSION: Gastric bypass results in a more robust PYY response to caloric intake, which, in conjunction with decreased ghrelin levels, may contribute to the sustained efficacy of this procedure. The findings provide further evidence for a role of gut-derived hormones in mediating appetite changes after gastric bypass and support further efforts to determine whether PYY(3-36) replacement could represent an effective therapy for obesity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16571843     DOI: 10.1038/oby.2006.25

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  36 in total

Review 1.  The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity.

Authors:  Christopher N Ochner; Charlisa Gibson; Susan Carnell; Carl Dambkowski; Allan Geliebter
Journal:  Physiol Behav       Date:  2010-05-08

Review 2.  Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction.

Authors:  Priscila C Sala; Raquel S Torrinhas; Steven B Heymsfield; Dan L Waitzberg
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

Review 3.  Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery.

Authors:  David E Cummings; Joost Overduin; Karen E Foster-Schubert; Molly J Carlson
Journal:  Surg Obes Relat Dis       Date:  2007 Mar-Apr       Impact factor: 4.734

4.  Changes in Bone Mineral Density in Patients with Type 2 Diabetes After Different Bariatric Surgery Procedures and the Role of Gastrointestinal Hormones.

Authors:  Fernando Guerrero-Pérez; Anna Casajoana; Carmen Gómez-Vaquero; Nuria Virgili; Rafael López-Urdiales; Laura Hernández-Montoliu; Jordi Pujol-Gebelli; Javier Osorio; Carolina Alves; Manuel Perez-Maraver; Silvia Pellitero; Anna Vidal-Alabró; Sonia Fernández-Veledo; Joan Vendrell; Nuria Vilarrasa
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

5.  Management of postgastric bypass noninsulinoma pancreatogenous hypoglycemia.

Authors:  Viney K Mathavan; Maurice Arregui; Chad Davis; Kirpal Singh; Anand Patel; James Meacham
Journal:  Surg Endosc       Date:  2010-03-31       Impact factor: 4.584

6.  Preoperative weight loss as a predictor of long-term success following Roux-en-Y gastric bypass.

Authors:  Sharon Alger-Mayer; John M Polimeni; Margaret Malone
Journal:  Obes Surg       Date:  2008-04-08       Impact factor: 4.129

7.  The role of malabsorption in bariatric surgery.

Authors:  Vivek N Prachand; John C Alverdy
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

8.  The paradox of the pouch: prompt emptying predicts improved weight loss after laparoscopic Roux-Y gastric bypass.

Authors:  Ehab Akkary; Shafik Sidani; Joseph Boonsiri; Sunkyung Yu; James Dziura; Andrew J Duffy; Robert L Bell
Journal:  Surg Endosc       Date:  2008-09-21       Impact factor: 4.584

9.  Guanylin and uroguanylin stimulate lipolysis in human visceral adipocytes.

Authors:  A Rodríguez; J Gómez-Ambrosi; V Catalán; S Ezquerro; L Méndez-Giménez; S Becerril; P Ibáñez; N Vila; M A Margall; R Moncada; V Valentí; C Silva; J Salvador; G Frühbeck
Journal:  Int J Obes (Lond)       Date:  2016-04-25       Impact factor: 5.095

Review 10.  Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

Authors:  Mousumi Bose; Blanca Oliván; Julio Teixeira; F Xavier Pi-Sunyer; Blandine Laferrère
Journal:  Obes Surg       Date:  2008-09-27       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.